combine@alvar.ug

Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination

Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination

Show simple record

dc.contributor.author Wamboga, Charles
dc.contributor.author Matovu, Enock
dc.contributor.author Bessell, Paul Richard
dc.contributor.author Picado, Albert
dc.contributor.author Bieler, Sylvain
dc.contributor.author Ndung'u, Joseph Mathu
dc.date.accessioned 2021-01-01T21:57:48Z
dc.date.available 2021-01-01T21:57:48Z
dc.date.issued 2017
dc.identifier.issn 1932-6203
dc.identifier.uri http://combine.alvar.ug/handle/1/48009
dc.description.abstract Introduction The incidence of gambiense human African trypanosomiasis (gHAT) in Uganda has been declining, from 198 cases in 2008, to only 20 in 2012. Interruption of transmission of the disease by early diagnosis and treatment is core to the control and eventual elimination of gHAT. Until recently, the format of available screening tests had restricted screening and diagnosis to central health facilities (passive screening). We describe a novel strategy that is contributing to elimination of gHAT in Uganda through expansion of passive screening to the entire population at risk. Methodology / Principal findings In this strategy, patients who are clinically suspected of having gHAT at primary health facilities are screened using a rapid diagnostic test (RDT), followed by parasitological confirmation at strategically located microscopy centres. For patients who are positive with the RDT and negative by microscopy, blood samples undergo further testing using loop-mediated isothermal amplification (LAMP), a molecular test that detects parasite DNA. LAMP positive patients are considered strong suspects, and are re-evaluated by microscopy. Location and upgrading of facilities to perform microscopy and LAMP was informed by results of georeferencing and characterization of all public healthcare facilities in the 7 gHAT endemic districts in Uganda. Three facilities were upgraded to perform RDTs, microscopy and LAMP, 9 to perform RDTs and microscopy, and 200 to screen patients with RDTs. This reduced the distance that a sick person must travel to be screened for gHAT to a median distance of 2.5km compared to 23km previously. In this strategy, 9 gHAT cases were diagnosed in 2014, and 4 in 2015. Conclusions This enhanced passive screening strategy for gHAT has enabled full coverage of the population at risk, and is being replicated in other gHAT endemic countries. The improvement in case detection is making elimination of the disease in Uganda an imminent possibility.
dc.description.sponsorship Bill & Melinda Gates FoundationBill & Melinda Gates Foundation
dc.description.sponsorship Republic and Canton of Geneva
dc.description.sponsorship German Federal Ministry of Education and Research through KfW
dc.description.sponsorship Swiss Government
dc.description.sponsorship UK government
dc.language English
dc.publisher PUBLIC LIBRARY SCIENCE
dc.relation.ispartof PLOS One
dc.title Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination
dc.type Article
dc.identifier.isi 000412845100128
dc.identifier.doi 10.1371/journal.pone.0186429
dc.identifier.pmid 223573
dc.publisher.city SAN FRANCISCO
dc.publisher.address 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
dc.identifier.volume 12
dc.identifier.issue 10
dc.subject.wc Multidisciplinary Sciences
dc.subject.sc Science & Technology - Other Topics
dc.description.oa DOAJ Gold
dc.description.oa Green Published
dc.description.pages 19
dc.subject.kwp Rhodesiense Sleeping Sickness
dc.subject.kwp Health Facilities
dc.subject.kwp Seeking Behavior
dc.subject.kwp Eastern Uganda
dc.subject.kwp Brucei
dc.subject.kwp Congo
dc.subject.kwp Risk
dc.identifier.articleno e0186429
dc.description.affiliation Minist Hlth, Kampala, Uganda
dc.description.affiliation Makerere Univ, Coll Vet Med Anim Resources & Biosecur COVAB, Kampala, Uganda
dc.description.affiliation Epi Intervent Ltd, Edinburgh, Midlothian, Scotland
dc.description.affiliation FIND, Geneva, Switzerland
dc.description.email Joseph.Ndungu@finddx.org
dc.description.corr Ndung'u, JM (corresponding author), FIND, Geneva, Switzerland.


This record appears in the collections of the following institution(s)

Show simple record

Search Entire Database


Browse

My Account